血栓-维拉:一种使用现代变量选择方法的多细胞血症维拉的新血栓风险模型.
Isidora Arsenovic1, Natasa Milic2,3, Nikola Grubor2
1Clinic of Hematology, University Clinical Center of Serbia, Belgrade, Serbia.
Expert review of hematology
|June 16, 2025
概括
一个新的临床评分,ThromboVera CS,有效地预测了多细胞血真 (PV) 患者的血栓形成风险. 这种工具有助于对高风险个体进行早期干预,可能改善结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 统计 统计 统计 统计
背景情况:
- 血栓形成是多细胞真血症 (PV) 的重要并发症,导致发病率和死亡率增加.
- 需要预测模型来识别高风险发生血栓事件的PV患者.
研究的目的:
- 开发和验证一种预测模型,用于对多细胞血真菌 (PV) 患者的血栓形成风险的预测.
- 为了创建一个临床分数,将PV患者分为不同类型的血栓形成风险.
主要方法:
- 对817名连续PV患者的回顾性研究,随访时间中位数为59个月.
- 利用贝叶斯逻辑回归与R2D2先验来预测血栓形成.
- 根据通过多变量分析识别的关键预测因素开发了ThromboVera CS评分.
主要成果:
- 血栓事件发生在13.2%的PV患者中.
- 血栓形成的关键预测因素包括查尔森并发症指数 (CCI),血小板与淋巴细胞的比率 (PLR),壮症和微血管症状.
- 通过ThromboVera CS得分,患者被分为低风险 (6.94%的血栓形成),中度风险 (15.76%) 和高风险 (48.78%) 的群体.
结论:
- ThromboVera CS 评分是一个可靠和用户友好的工具,用于预测PV中的血栓形成.
- 早期识别使用ThromboVera CS的高风险PV患者可以促进及时干预.
- 这一分数有可能通过实现有针对性的管理策略,显著改善患者的治疗结果.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
155
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
155
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
156
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
156
Venous Thrombosis I: Introduction
47
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
47
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
234
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
234


